Company Ticker News January 10, 2022CureVac Outlines Upcoming Catalysts For Vaccine Programs 0 0 Share
Company Ticker News November 19, 2021CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2021 and Provides Business Update 0 0 Share
Press Release November 18, 2021CureVac Publishes in Nature Preclinical Data of Second-Generation COVID-19 Candidate, CV2CoV, Demonstrating Comparable Antibody Levels to Licensed mRNA Vaccine 0 0 Share
Press Release October 2, 2021Vaccine Stocks: Why MRNA, VXRT, CVAC and NVAX Stocks Need a Band-Aid Today 0 0 Share
Company Ticker News August 16, 2021CureVac Shares Increase Over 8% Pre-Market: Why It Happened 0 0 Share
Company Ticker News July 10, 2021Can CureVac Win Market Share With Only 48% Vaccine Efficacy? 0 0 Share
Company Ticker News July 1, 2021CureVac Stock Drops After Final Results Confirm Its COVID-19 Vaccine Trails Rivals 0 0 Share
Company Ticker News July 1, 2021CureVac to 'plow forward' with Covid vaccine despite disappointing results 0 0 Share
